Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) [Phase 1, Phase 2]
ELU001, studied in Phase 1/2 in FRα-overexpressing solid tumors, has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma [NA]
Clinical trial update for advanced endometrial cancer evaluating paclitaxel and carboplatin with or without an anthracycline as adjuvant che…
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: A Study of XS-02 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update covers XS-02 capsules in advanced solid tumors (including ovarian, breast, and endometrial cancers) in Phase 1/2,…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Sentinel Node Mapping in High Risk Endometrial Cancer [NA]
This entry notes a clinical trial evaluating sentinel lymph node mapping in high-risk endometrial cancer; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Virtual Reality's Role in See&Treat Hysteroscopy [NA]
A completed clinical trial from Federico II University evaluated the use of virtual reality-assisted see-and-treat hysteroscopy for endometr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
A translational study update investigating MSS status, TP53 mutation, and chromosomal instability in endometrial cancer, with the trial curr…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol [Phase 3]
Phase 3 randomized trial in endometrial/uterine cancers compares cisplatin plus radiation followed by carboplatin/paclitaxel versus a carbop…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer [NA]
A clinical trial at Peking University People's Hospital is evaluating fertility-sparing therapy for stage IA, grade 2 endometrial cancer, an…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding. [NA]
A clinical trial is investigating Pipelle under ultrasound guidance (PUG) to evaluate post-menopausal bleeding, and recruitment is currently…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: EC_ItaLynch: Mainstreaming the Diagnosis of Lynch Syndrome
This clinical trial evaluates a streamlined approach to diagnosing Lynch syndrome in the context of Lynch syndrome and endometrial cancer. T…
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer [Phase 2]
Phase 2 trial updates of avelumab in recurrent or persistent endometrial cancer, including MSS/MSI-H/POLE-mutated disease and combinations w…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Trial status update indicates that a study using ultrasound-guided Tru-Cut biopsy for pelvic masses is recruiting, involving patients with o…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Rucaparib vs Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer [Phase 2]
Phase 2 trial evaluating maintenance Rucaparib versus placebo in metastatic or recurrent endometrial cancer with results posted.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of PRT3645 conducted by Prelude Therapeutics in patients with several advanced solid tumors has completed, including breast …
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer [Phase 3]
A Phase 3 clinical trial update on the combination of Anlotinib hydrochloride capsules with TQB2450 for endometrial cancer, currently NOT_YE…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors [Phase 1]
A phase 1 trial evaluating CLDN6/GPC3/Mesothelin/AXL-CAR-NK cell therapy for advanced solid tumors is currently recruiting, including stage …
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer [NA]
A clinical trial evaluating postoperative hypofractionated intensity-modulated radiotherapy for endometrial cancer is currently recruiting, …
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.
A retrospective cohort study evaluating ultrasound performance in women with postmenopausal or abnormal uterine bleeding across White and Bl…
-
CLINICAL_TRIALS research · 2024-05-31Clinical Trial Update: Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
A recruiting clinical trial evaluating immunotolerance and immune profiling in the endometrial cancer tumor microenvironment to improve risk…
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma [Phase 2]
A Phase 2 trial evaluating SYD985 in HER2-expressing recurrent, advanced, or metastatic endometrial cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study [Phase 2]
A Phase 2 study (FUCHSia) evaluating fulvestrant for hormone-sensitive gynecologic cancers has completed, investigating its activity in uter…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ILB2109 in combination with toripalimab in patients with advanced solid malignancies, currently recrui…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women [NA]
This ClinicalTrials.gov entry describes a prospective study evaluating endometrial cancer and endometrial hyperplasia in childbearing-age wo…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of camrelizumab and fluzoparib for TP53-mutated endometrial cancer is currently recruiti…